Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Cell & Gene: The Podcast by Erin Harris

We love to hear from our listeners. Send us a message. On episode 125 of Cell & Gene: The Podcast, Host Erin Harris talks to Halloran Consulting Group's Monika Swietlicka to discuss how the FDA is increasing flexibi...View more